Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus

Eric M. Cohen(Brown University), Karen H. Costenbader(Brigham and Women's Hospital), Kristin M. D’Silva(Brigham and Women's Hospital), Mary Beth F. Son(Boston Children's Hospital), David Joseph Kreps(Brigham and Women's Hospital)
Lupus
February 16, 2018
10.1177/0961203318759428
Cited by 20

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
|Nature Genetics|2008|542